QQ客服 官方微博 反馈留言

浏览/检索结果: 共10条，第1-10条 帮助 限定条件 发表日期：2020    专题：合肥物质科学研究院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Beyond Blocking: Engineering RNAi-Mediated Targeted Immune Checkpoint Nanoblocker Enables T-Cell-lndependent Cancer Treatment 期刊论文 ACS NANO, 2020, 卷号: 14 作者:  Han, Xiaoyan;  Wang, Linlin;  Li, Ting;  Zhang, Jiahui;  Zhang, Dailiang 收藏  |  浏览/下载：54/0  |  提交时间：2021/03/15 immune checkpoint blockade  RNAi engineering  nanostructure  NSCLC  cancer immunotherapy   Lipid-oligonucleotide conjugates for bioapplications 期刊论文 NATIONAL SCIENCE REVIEW, 2020, 卷号: 7 作者:  Li, Xiaowei;  Feng, Kejun;  Li, Long;  Yang, Lu;  Pan, Xiaoshu 收藏  |  浏览/下载：104/0  |  提交时间：2021/03/15 lipid-oligonucleotide  DNA nanostructure  biosensor  biomedicine  bio analysis  nanoreactor   Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report 期刊论文 FRONTIERS IN ONCOLOGY, 2020, 卷号: 10 作者:  Yang, Zi-yan;  Huang, Jia-huan;  Chen, Bo;  Xu, Chun-wei;  Lei, Lei 收藏  |  浏览/下载：27/0  |  提交时间：2020/11/30 salivary duct carcinoma  tyrosine kinase inhibitor  pyrotinib  HER2 positive  targeted   Discovery of a highly potent and selective Bruton's tyrosine kinase inhibitor avoiding impairment of ADCC effects for B-cell non-Hodgkin lymphoma 期刊论文 SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 卷号: 5 作者:  Liu, Juan;  Liang, Qianmao;  Wang, Aoli;  Zou, Fengming;  Qi, Ziping 收藏  |  浏览/下载：18/0  |  提交时间：2020/11/30 PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9 作者:  Wei, Qing;  Yuan, Xing;  Li, Jingjing;  Xu, Qi;  Ying, Jieer 收藏  |  浏览/下载：30/0  |  提交时间：2020/11/30 Programmed death 1 (PD-1)  gastric cancer (GC)  immune checkpoint inhibitors  immunotherapy  apatinib   Circular Bispecific Aptamer-Mediated Artificial Intercellular Recognition for Targeted T Cell Immunotherapy 期刊论文 ACS NANO, 2020, 卷号: 14 作者:  Yang, Yu;  Sun, Xiaoqi;  Xu, Jun;  Cui, Cheng;  Yazd, Hoda Safari 收藏  |  浏览/下载：41/0  |  提交时间：2020/10/26 recognition-then-activation  circular bispecific aptamer  cb-aptamer  adoptive T cell immunotherapy  T cell immunotherapy  on shelf   Aptamer Enables Consistent Maytansine Delivery through Maintaining Receptor Homeostasis for HER2 Targeted Cancer Therapy 期刊论文 BIOCONJUGATE CHEMISTRY, 2020, 卷号: 31 作者:  Tan, Yan;  Peng, Yongbo;  Ai, Lili;  Li, Yingying;  Qu, Yi-xin 收藏  |  浏览/下载：19/0  |  提交时间：2020/11/26 cfDNA changes for monitoring of targeted therapy in a primary EGFR mutation lung adenocarcinoma 期刊论文 TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 卷号: 9 作者:  He, Qiong;  Zhu, Xian;  Shi, Xun;  Lin, Chen;  Jin, Yin 收藏  |  浏览/下载：23/0  |  提交时间：2020/11/26 Construction of Bispecific Aptamer-Drug Conjugate by a Hybrid Chemical and Biological Approach 期刊论文 BIOCONJUGATE CHEMISTRY, 2020, 卷号: 31 作者:  Sun, Yang;  Gao, Fei;  Yang, Cai;  Li, Yingying;  Jin, Cheng 收藏  |  浏览/下载：25/0  |  提交时间：2020/11/26 Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer 期刊论文 FRONTIERS IN ONCOLOGY, 2020, 卷号: 10 作者:  Lin, Chen;  Shi, Xun;  Zhao, Jun;  He, Qiong;  Fan, Yun 收藏  |  浏览/下载：21/0  |  提交时间：2020/10/26 tumor mutation burden (TMB)  clinical benefit  epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs)  chemotherapy  non-small cell lung cancer (NSCLC)